The expression of the genes that are differentially expressed between these two subtypes may represent a general indicator of neuroblastoma aggressiveness, since corresponding expression behaviour can be observed in low stage MYCN non-amplified tumours as well as advanced stage MYCN amplified tumours. Here, MYCN is linked to neuroblastoma.